Healio (1/30, Welsh) reports, “In utero exposure to amphetamine/dextroamphetamine or methylphenidate was not associated with increased risks for neurodevelopmental disorders in children, according to cohort study results.” Investigators came to this conclusion after conducting “a cohort study using health care utilization Medicaid data from 2000 to 2018 and MarketScan Commercial Claims Database data from 2003 to 2020 to identify insured pregnant individuals aged 12 to 55 years in the U.S.” The findings were published in JAMA Psychiatry.
Related Links:
— “Maternal ADHD drug use not tied to neurodevelopmental disorders, autism in children,” Erin T. Welsh, MA, Healio, January 30, 2024